Awards

Each year, ISoP honors individuals in the following categories: 

  • Lewis B. Sheiner Lecturer Award
  • ISoP Innovation Award
  • ISoP Leadership Award
  • ISoP Outstanding Research Manuscript Award
  • ISoP Emerging Scientist Award
  • ISoP Unsung Hero Award

View the list of past recipients here

The purpose of the Lewis B Sheiner Lecturer Award is to recognize the outstanding lifetime achievements of a distinguished scientist or researcher who has continued the legacy of excellence in pharmacometric research and leadership established by Lewis B. Sheiner. In particular, pharmacometric scientists or researchers involved in the application of the circle of excellence: Integration–Innovation–Impact (JCP 2010;50:S6-S160) to enhance research, development, regulatory evaluation, and/or utilization of therapeutic products may be considered for this award.

Eligibility Criteria

The candidate must:

  • Be a leader and actively advance and impact the scientific discipline of pharmacometrics
  • Have a continued track record of quality scientific publications in pharmacometrics
  • The following individuals are ineligible for ISoP Award nomination during AND until one year after completion of serving their term or stepping down from their position:
    • ISoP Board members (Executive Committee members included)
    • Leadership (Chair, Vice Chair, and/or Chair Elect) of the following ISoP committees – Awards Committee, Conference Committee, Finance Committee, and Nominations Committee
  • Individuals who have won an ISoP Award within the preceding 2 years are ineligible for nomination of this ISoP Award
  • Be capable of delivering an engaging and comprehensive lecture on pharmacometrics
  • Attend the ACoP Annual Meeting to receive the Award and deliver the lecture

Nomination Procedure and Package

  • Nominations can be made by any ISoP member.
  • The call for nominations for this Award is open through the published deadline.
  • The nomination package should contain the following:
    1. Nomination letter. The letter must clearly document why the candidate should be considered, above all others, for this distinguished award.
    2. Curriculum Vitae (CV) of the nominee. The CV must contain sufficient information to inform the selection process without additional research.
    3. List of select publications from the candidate (as first and/or senior author) that illustrate the nominee’s candidacy particularly well.
  • The nomination package must be sent by the call deadline here.

Selection Process

The Award recipient will be selected based on the following steps:

  • Individual scoring of the nominated candidates by the ISoP Awards Committee members
  • Ranking of the nominated candidates based on the highest total score and recommendation of the recipient by the ISoP Awards Committee
  • Approval of the Award recipient by the ISoP Board

Notification of Award:

  • The recipient of the award will be notified via email promptly after selection.
  • The recipient will be requested to RSVP within 15 days to accept/decline the Award.
  • The name of the award recipient will be publicly announced to the ISoP community after the recipient accepts the award.

More about Dr. Lewis B. Sheiner 

Dr. Lewis B. Sheiner, MD, PhD (honoris causa), also known as the father of the “learn and confirm” paradigm of drug development, is internationally recognized for his work in pharmacokinetic (PK) and pharmacodynamic (PD) modeling and simulation. He pioneered the scientific discipline of pharmacometrics with an academic career focused on developing and applying mathematical and statistical methods to problems in clinical pharmacology. In a close and extended collaboration with Dr. Stuart Beal, they developed the methodology for the population approach to PK/PD, based on the estimation of non-linear mixed effects modeling (NONMEM), and further developed the NONMEM software system. The latter quickly became the standard software in many pharmaceutical industries and at the U. S. Food and Drug Administration (FDA) for characterizing PK and PD data acquired during clinical drug studies.

Dr. Sheiner authored more than 200 articles and book chapters. He served on the Editorial Board of Clinical Pharmacology & Therapeutics and was an editor of the Journal of Pharmacokinetics and Pharmacodynamics. He was a former member of the Antiviral Drugs Advisory Committee of the FDA and a member of the Clinical Pharmacology Subcommittee of the Advisory Committee for Pharmacological Science of the FDA. His honors and awards include an honorary doctorate degree from Uppsala University in Sweden, the Rawls Palmer Progress in Medicine Award from the ASCPT, and numerous named lectureships at universities throughout the world.

The ISoP Innovation Award was established in 2011 to acknowledge individuals whose scientific and innovative contributions have advanced/revolutionized the field of pharmacometrics and related scientific areas.

The purpose of the ISoP Innovation Award is to recognize an outstanding scientist or an exceptional team of scientists for novel, innovative, creative, and remarkable scientific, technical, and methodological contributions to the scientific field of pharmacometrics.

Eligibility Criteria

  • Be a scientist, researcher, or team who coined, genuinely applied, and/or played an integral role in the introduction of new and innovative concepts, approaches, or tools that have substantially advanced and broadly impacted the scientific discipline of pharmacometrics

  • Peer-reviewed scientific publications supporting the innovation are not a requirement for this award but are considered significantly advantageous

  • The following individuals are ineligible for ISoP Award nomination during AND until one year after completion of serving their term or stepping down from their position:

    • ISoP Board members (Executive Committee members included)

    • Leadership (Chair, Vice Chair and/or Chair Elect) of the following ISoP committees – Awards Committee, Conference Committee, Finance Committee and Nominations Committee.

Nomination Procedure and Package

  • Any ISoP member can make nominations.
  • The call for nominations for this Award is open through the published deadline.
  • The nomination package should contain the following:
    1. Nomination letter. The letter must clearly document why the candidate should be considered, above all others, for this distinguished award.
    2. Curriculum Vitae (CV) of the nominee. The CV must contain sufficient information to inform the selection process without additional research.
  • The nomination package must be submitted by the call deadline here.

Selection Process

The Award recipient will be selected based on the following steps:

  • Individual scoring of the nominated candidates by the ISoP Awards Committee members
  • Ranking of the nominated candidates based on the highest total score and recommendation of the recipient by the ISoP Awards Committee
  • Approval of the Award recipient by the ISoP Board

Notification of Award

  • The recipient of the award will be notified via email promptly after selection.
  • The recipient will be requested to RSVP within 15 days to accept/decline the Award.
  • The name of the Award recipient will be publicly announced to the ISoP community after acceptance of the Award by the recipient.

Recognition of Award Recipient

The recipient of the ISoP Innovation Award will be recognized at the opening ceremony of the ACoP Annual Meeting. The recipient will receive a plaque and the ACoP Annual Meeting registration fee will be reimbursed by ISoP.

The ISoP Leadership Award was established in 2009 to acknowledge individuals whose leadership contributions have advanced the field of pharmacometrics and related scientific areas.

The purpose of the ISoP Leadership Award is to recognize an outstanding individual (not necessarily a scientist) for outstanding sustained leadership, mentorship, and outreach contributions to the field of pharmacometrics and to the development of the strategic vision for the future direction of the field and its application of the circle of excellence: Integration–Innovation–Impact (JCP 2010;50:S6-S160) to enhance research, development, regulatory evaluation and/or utilization of therapeutic products.

Eligibility Criteria

  • Have demonstrated excellence in leadership involving people, events, programs, projects, and/or teams in the field of pharmacometrics

  • Have made major long-term contributions that enabled the growth of opportunities that have substantially advanced and broadened the visibility, connectivity, application, and impact of pharmacometrics

  • Be an excellent role model

  • Inspire others to work collaboratively and creatively

  • Be actively involved in mentorship and development of others

  • Promote a work environment that is respectful, collegial, and supportive

  • The following individuals are ineligible for ISoP Award nomination during AND until one year after completion of serving their term or stepping down from their position:

    • ISoP Board members (Executive Committee members included)
    • Leadership (Chair, Vice Chair, and/or Chair Elect) of the following ISoP committees – Awards Committee, Conference Committee, Finance Committee, and Nominations Committee

  • Individuals who have won an ISoP Award within the preceding 2 years are ineligible for nomination of this ISoP Award

Nomination Procedure and Package

  • Any ISoP member can make nominations.
  • The call for nominations for this Award is open through the published deadline.
  • The nomination package should contain the following:
    1. Nomination letter. The letter must clearly document why the candidate should be considered, above all others, for this distinguished award.
    2. Curriculum Vitae (CV) of the nominee. The CV must contain sufficient information to inform the selection process without additional research.
  • The nomination package must be submitted by the call deadline here.

Selection Process

The Award recipient will be selected based on the following steps:

  • Individual scoring of the nominated candidates by the ISoP Awards Committee members
  • Ranking of the nominated candidates based on the highest total score and recommendation of the recipient by the ISoP Awards Committee
  • Approval of the Award recipient by the ISoP Board

Notification of Award:

  • The recipient of the award will be notified via email promptly after selection
  • The recipient will be requested to RSVP within 15 days to accept/decline the Award
  • The name of the award recipient will be publicly announced to the ISoP community after the recipient accepts the award.

Recognition of Award Recipient

The recipient of the ISoP Leadership Award will be recognized at the opening ceremony of the ACoP Annual Meeting. The recipient will receive a plaque and the ACoP Annual Meeting registration fee will be reimbursed by ISoP.

The ISoP Outstanding Research Manuscript Award was established in 2017 (named Technical Manuscript Award in 2017-2018) to recognize authors of an outstanding research manuscript in the field of pharmacometrics published in the preceding calendar year. The nominated manuscript should be original research of a theoretical or applied nature in the fields of pharmacometrics, statistics, systems-based modeling and simulation, or related scientific fields.

The purpose of the ISoP Outstanding Research Manuscript Award is to recognize the authors of a particularly outstanding manuscript published in the format of a scientific publication in any of a variety of quality peer-reviewed journals.

Eligibility Criteria

  • Have broad application and potential or immediate impact in one or more of the above-cited scientific fields

  • Demonstrate quality, clarity, and significance of the research question, methodology, and interpretation of the findings/results

  • Involve innovation and creativity in the analysis of data

  • Contribute to the advancement of pharmacometric analysis, clinical and/or basic science(s), and/or regulatory review related to drug therapy (efficacy) and/or safety (toxicity)

  • Exhibit technical excellence and high quality in the methodological approach (statistical, pharmacometrics, systems-based approaches…etc.)

  • Be clearly written and easily understood by readers from diverse scientific fields

  • Must have the first appearance with a DOI # in a peer-reviewed publication in the calendar year (January 1 – December 31) preceding the selection

  • Tutorials and reviews will not be considered for this award

Nomination Procedure and Package

  • Any ISoP member can make nominations.
  • The call for nominations for this Award is open through the published deadline.
  • The nomination package should contain a nomination letter documenting clearly why the manuscript should be considered, above all others, for this distinguished award.
  • The nomination package must be submitted by the call deadline here.

Selection Process

The Award will be selected based on the following steps:

  • Individual scoring of the nominated manuscripts by the ISoP Awards Committee members
  • Ranking of the manuscripts on the highest total score and recommendation of the recipient by the ISoP Awards Committee
  • Approval of the Award by the ISoP Board

Notification of Award

  • The first author and the corresponding author of the manuscript will be notified via email after selection.
  • The authors will be requested to RSVP within 15 days to accept/decline the Award.
  • The names of all authors, the title of the manuscript, and the publishing journal will be publicly announced to the ISoP community after acceptance of the Award.

Recognition of Award Recipient

The authors of the ISoP Outstanding Research Manuscript Award will be recognized at the opening ceremony of the ACoP Annual Meeting. The first author will receive a plaque and have the ACoP Annual Meeting registration fee reimbursed by ISoP. In case the first author is unable to attend the ACoP Annual Meeting, a designated co-author will be designated to receive the award on his/her behalf.

Established in 2019, the ISoP Emerging Scientist Award highlights the extraordinary professional efforts of an ISoP member who, while within 5 years of a first professional appointment, has made a significant impact in some aspect of the fields of pharmacometrics, applied statistics, systems-based modeling and simulation, or any related scientific field.

Eligibility Criteria

  • Be within 5 years of the award of either MS, Pharm D, PhD, or MD degree (or highest alternative qualification) in the fields of pharmacometrics, applied statistics, systems-based modeling and simulation, or any related field

  • Be a professional with no more than 5 years of full-time professional appointment in the fields of pharmacometrics, applied statistics, systems-based modeling and simulation, or any related field. (Post-doctoral fellows, research associates employed full time in academic, government, or commercial organizations after completing their graduate degree are eligible for this award)

  • Be a member of ISoP

  • Students are not eligible for this Award

Nomination Procedure and Package

The nominations must include:

  • The nominee’s current Curriculum Vitae (CV)
  • Two letters of support from ISoP members describing the nominee’s impact in aspects of the fields of pharmacometrics, applied statistics, systems-based modeling and simulation, or any related field.
  • The nomination package must be submitted by the call deadline here.

Selection Process

The Award recipient will be selected based on the following steps:

  • Individual scoring of the nominated candidates by the ISoP Awards Committee members
  • Ranking of the nominated candidates based on the highest total score and recommendation of the recipient by the ISoP Awards Committee
  • Approval of the Award recipient by the ISoP Board

Notification of Award:

  • The recipient of the award will be notified via email promptly after selection
  • The recipient will be requested to RSVP within 15 days to accept/decline the Award
  • The name of the Award recipient will be publicly announced to the ISoP community after acceptance of the Award by the recipient.

Recognition of Award Recipient

The recipient of the ISoP Emerging Scientist Award will be recognized at the opening ceremony of the ACoP Annual Meeting. The recipient will receive a plaque and the ACoP Annual Meeting registration fee will be reimbursed by ISoP.

Beginning in 2019, the ISoP Unsung Hero Award recognizes noteworthy candidate(s) who are ISoP members and have demonstrated significant dedication, commitment, and contributions (of any kind) to the effective operations of ISoP. There is no limit established on the number of ISoP Unsung Hero Award(s) to be awarded every year (i.e., can be more than one or none).

Eligibility Criteria

  • Be an ISoP member

  • Have demonstrated significant contributions (of any kind) to the effective operations of ISoP

  • The following individuals are ineligible for ISoP Award nomination during AND until one year after completion of serving their term or stepping down from their position:

    • ISoP Board members (Executive Committee members included)
    • Leadership (Chair, Vice Chair, and/or Chair Elect) of the following ISoP committees – Awards Committee, Conference Committee, Finance Committee, and Nominations Committee

  • Individuals who have won an ISoP Award within the preceding 2 years are ineligible for nomination of this ISoP Award

  • Not be an ISoP Fellow

The Unsung Hero Award is based solely on contributions to ISoP. Hence, any ISoP member with the above criteria is eligible to be nominated for this Award.

Nomination Procedure and Package

Details are as follows:

  • Nominations must include a letter of nomination from an ISoP member detailing the nominee’s qualifications for the Award
  • The call for nominations for this Award is open through the published deadline.
  • The nomination package must be submitted by the deadline here.

Selection Process

The Award recipient(s) will be selected based on the following three steps:

  • Individual scoring of the nominated candidates by the ISoP Awards Committee members
  • Ranking of the nominated candidates based on the highest total score and recommendation of the recipients by the ISoP Awards Committee
  • Approval of the Award recipients by the ISoP Board

Notification of Award:

  • The recipients of the award will be notified via email promptly after selection
  • The recipients will be requested to RSVP within 15 days to accept/decline the Award
  • The names of the recipients of this Award will be publicly announced to the ISoP community after acceptance of the Award

Recognition of Award Recipient(s)

The recipients of the ISoP Unsung Hero Awards will be recognized at the opening ceremony of the ACoP Annual Meeting. The recipient(s) will receive a plaque and the ACoP Annual Meeting registration fee will be reimbursed by ISoP.